Equities

Burning Rock Biotech Ltd

Burning Rock Biotech Ltd

Actions
  • Price (EUR)3.28
  • Today's Change-0.08 / -2.38%
  • Shares traded0.00
  • 1 Year change-63.76%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6299081,497
Total Receivables, Net168170158
Total Inventory69130123
Prepaid expenses162131
Other current assets, total2.923012
Total current assets8841,2591,821
Property, plant & equipment, net144300406
Goodwill, net------
Intangibles, net0.961.995.15
Long term investments0.340.690.91
Note receivable - long term5.325.11--
Other long term assets5.092145
Total assets1,0401,5872,279
LIABILITIES
Accounts payable185163
Accrued expenses95191150
Notes payable/short-term debt002.37
Current portion long-term debt/capital leases----0
Other current liabilities, total151169157
Total current liabilities263411372
Total long term debt000
Total debt002.37
Deferred income tax------
Minority interest------
Other liabilities, total8.231861
Total liabilities272429433
SHAREHOLDERS EQUITY
Common stock0.140.140.14
Additional paid-in capital4,8494,5834,281
Retained earnings (accumulated deficit)(3854)(3200)(2229)
Treasury stock - common(66)(59)--
Unrealized gain (loss)------
Other equity, total(162)(166)(207)
Total equity7681,1581,845
Total liabilities & shareholders' equity1,0401,5872,279
Total common shares outstanding102103105
Treasury shares - common primary issue------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.